You have 9 free searches left this month | to do more

olaparib

Olaparib is a drug used to treat Ovarian Cancer, Breast Cancer, Recurrent Primary Peritoneal Carcinoma, and other conditions. Olaparib is being actively studied in 172 studies and prior, has been studied in 29.

Top SponsorsTop SitesTop Investigators
AstraZenecaResearch SiteZahi Mitri, MD, MS
National Cancer Institute (NCI)Dana-Farber Cancer InstituteCCTU- Cancer Theme
M.D. Anderson Cancer CenterM D Anderson Cancer CenterDo-Youn Oh
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Not yet recruiting
  • Cancer
  • Amsterdam, Netherlands
  • +1 more
2021-10-04
Oct 4, 2021
N
Recruiting
  • Ovarian Cancer
  • Kashiwa, Chiba, Japan
  • +2 more
2021-01-31
Jan 31, 2021
M
Active, not recruiting
  • Prostate Cancer Aggressiveness
  • Prostate Carcinoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-04-02
Apr 2, 2021
D
Active, not recruiting
  • Advanced Gastric Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-09-22
Sep 22, 2021
I
Active, not recruiting
  • Neoplasms, Germ Cell and Embryonal
  • Olaparib
  • Meldola, FC, Italy
  • +1 more
2021-02-25
Feb 25, 2021
N
Completed
  • Mesothelioma
  • Olaparib
  • ClinOmics
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-03-16
Mar 16, 2021
D
Recruiting
  • Osteosarcoma
  • Osteosarcoma Recurrent
  • San Francisco, California
  • +1 more
2021-10-12
Oct 12, 2021
U
Recruiting
  • Mesothelioma
  • Homologous Recombination Deficiency
  • Olaparib
  • Chicago, Illinois
    University of Chicago Medical Center
2021-05-12
May 12, 2021
U
Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Olaparib
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-06-28
Jun 28, 2021
C
Recruiting
  • Metastatic Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
2021-04-30
Apr 30, 2021
S
Recruiting
  • Advanced Gastric Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2021-08-18
Aug 18, 2021
T
Completed
  • Locally Advanced Malignant Neoplasm
  • +2 more
  • radiotherapy
  • olaparib
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
2021-08-03
Aug 3, 2021
M
Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Olaparib
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-07
May 7, 2021
T
Recruiting
  • Breast Cancer Metastatic
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
2021-07-16
Jul 16, 2021
S
Active, not recruiting
  • Breast Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-06-18
Jun 18, 2021
S
Completed
  • SCLC
  • Seoul, Korea, Republic of
    Samsung Medical Center
2021-02-16
Feb 16, 2021
T
Active, not recruiting
  • Ovarian Cancer
  • Olaparib
  • +2 more
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
2021-08-05
Aug 5, 2021
S
Recruiting
  • Ovarian Cancer
  • Olaparib
  • Pittsburgh, Pennsylvania
    Magee Women's Hospital of UPMC
2021-09-03
Sep 3, 2021
I
Recruiting
  • Soft-tissue Sarcoma
  • Olaparib
  • Concomitant Radiotherapy
  • Bordeaux, France
  • +4 more
2021-05-04
May 4, 2021
L
Recruiting
  • Pulmonary Arterial Hypertension
  • Olaparib
  • Edmonton, Alberta, Canada
  • +2 more
2021-08-27
Aug 27, 2021
S
Recruiting
  • Metastatic Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2021-09-09
Sep 9, 2021
S
Recruiting
  • Cervical Cancer
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
2021-06-22
Jun 22, 2021
D
Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
2020-12-22
Dec 22, 2020
M
Recruiting
  • Breast Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
2021-08-27
Aug 27, 2021